0

Shashi Kanth Muni

MSN Laboratories Pvt. Ltd, India

Presentation Title:

Heart failure management from African perspective: Consensus statement on urgent need for action

Abstract

Purpose: The primary aim of this consensus is to identify strategies for diagnosing, treating, and managing heart failure in Africa. 

Methods: The development of involved a combination of literature review, expert consultations, and consensus-building workshops. A panel of experts was convened from various African countries to capture geographical diversity. Multiple discussions were held with focus on challenges in diagnosing heart failure with limited resources. 

Results: Following a series of discussions, we prepared a manuscript that underwent peer review to validate its credibility and scientific rigor. This methodological approach demonstrates a commitment to evidence-based practice while also recognizing the need for solutions adapted to local contexts, with the goal of improving heart failure outcomes among Africa's diverse population.

Conclusion: In Africa, heart failure diagnosis often relies on echocardiography due to scarce BNP testing. Guideline-Directed Medical Therapy is often unaffordable, with medication access being a key challenge. Co-morbidities frequently complicate patient management.

Biography

Shashi Kanth Muni is an accomplished physician with more than 16 years of experience in medical affairs and clinical research. He is currently working as head of medical affairs and lead for rare disease portfolio at a pharmaceutical company based out of India. Previously, he worked as medical lead for India’s first indigenous COVID-19 vaccine called “Covaxin”. He has experience in conducting Phase 1 to Phase 3 clinical trials for vaccines intranasal SARS-CoV-2 vaccine, intradermal SARS-CoV-2 Vaccine, cholera vaccine, and heterologous vaccine. He has over 10 publications and is interested in driving access to medicines and improving healthcare outcomes.